Here's How Much You Would Have Made Owning Chemed Stock In The Last 20 Years
Chemed Is Maintained at Outperform by RBC Capital
Chemed Analyst Ratings
Chemed | 10-Q: Q1 2025 Earnings Report
Express News | Chemed Corp : RBC Raises Target Price to $674 From $667
Oppenheimer Maintains Chemed(CHE.US) With Buy Rating, Maintains Target Price $650
Chemed's Earnings Call: Mixed Sentiment With Growth and Challenges
Chemed (CHE) Gets a Buy From Oppenheimer
Chemed First Quarter 2025 Earnings: EPS Misses Expectations
BofA Securities Maintains Chemed(CHE.US) With Buy Rating, Maintains Target Price $708
Q1 2025 Chemed Corp Earnings Call
Top Gap Ups and Downs on Thursday: IBM, NOW, TXN and More
Earnings Call Summary | Chemed(CHE.US) Q1 2025 Earnings Conference
Chemed Outlines 2025 Growth Strategies Amid Strong VITAS Momentum and Roto-Rooter Recovery
Express News | Chemed Shares Are Trading Lower. The Company Reported Q1 Financial Results
Chemed Corporation (CHE): A Bull Case Theory
Chemed's Strong Q1 Performance and Growth Potential Justify Buy Rating
CHEMED Earnings Results: $CHE Reports Quarterly Earnings
Chemed: Q1 Earnings Snapshot
Chemed | 8-K: Chemed Reports First-Quarter 2025 Results